- NBIX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-3ASR Filing
Neurocrine Biosciences (NBIX) S-3ASRAutomatic shelf registration
Filed: 15 Feb 17, 12:00am
Exhibit 12.1
STATEMENT REGARDING COMPUTATION OF RATIOS
(in thousands)
Year Ended December 31, | ||||||||||||||||||||
2012 | 2013 | 2014 | 2015 | 2016 | ||||||||||||||||
Earnings: | ||||||||||||||||||||
Pretax income (loss) | 5,025 | (46,090 | ) | (60,542 | ) | (88,929 | ) | (141,090 | ) | |||||||||||
Add fixed charges | 2,807 | 2,568 | 2,295 | 1,984 | 1,633 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total Earnings | 7,832 | (43,522 | ) | (58,247 | ) | (86,945 | ) | (139,457 | ) | |||||||||||
Fixed charges: | ||||||||||||||||||||
Interest expensed, including amortization of debt discount and deferred financing costs | 0 | 0 | 0 | 0 | 0 | |||||||||||||||
Estimated interest component of rent expense | 2,807 | 2,568 | 2,295 | 1,984 | 1,633 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total fixed charges | 2,807 | 2,568 | 2,295 | 1,984 | 1,633 | |||||||||||||||
Ratio of earnings to fixed charges | 2.8 | N/A | N/A | | N/A | | N/A | |||||||||||||
Deficiency of earnings available to cover fixed charges | — | (46,090 | ) | (60,542 | ) | (88,929 | ) | (141,090 | ) |